Trending Now
Fate Therapeutics Inc. (NASDAQ:FATE) Receives FDA Approval For Its FT538 iPSC...
Fate Therapeutics Inc. (NASDAQ:FATE) has announced that the FDA has cleared its Investigational New Drug FT538 application, which is the first iPSC-derived, CRISPR-edited cell...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Brickwell Biotech Inc. (NASDAQ:BBI) Announce Encouraging Phase 3 Sofprironium Bromide Study...
Brickwell Biotech Inc. (NASDAQ:BBI) has released encouraging the third phase pivotal study results from Kaken Pharmaceuticals Co. Ltd. its Japanese-based development partner.
Phase 3 Kaken...
MAKE IT MODERN
LATEST REVIEWS
NFT Stocks Could Regain Momentum as Risk Trades Rally (CYIO, PLBY,...
The NFT revolution could be regaining some life, with recent rallies in key related stocks and several major stories hitting the newswires over recent...
MAKE IT MODERN
PERFORMANCE TRAINING
Bitcoin Stocks Back in the Spotlight: Fresh Ideas (BITO, EPAZ, HOOD, COIN, SQ, ARBK,...
As Bitcoin breaks out to new all-time highs following the launch of its first SEC-sanctioned ETF this week, all eyes turn toward...
The FDA Agrees With Aldeyra Therapeutics Inc. (NASDAQ:ALDX) On RASP Inhibitor In Dry Eye...
Aldeyra Therapeutics Inc. (NASDAQ:ALDX) has announced that it has reached an agreement with the FDA regarding the uses of reactive aldehyde species (RASP) as...
Stability and Dividend Potential of Healthcare Stocks (GILD,BMY,DHR)
Recent market volatility has shifted investor focus on on stability and dividend potential of healthcare stocks. The focus is on pharmaceutical and...
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Announces a Research and Option Agreement with Kansas State...
When Covid-19 hit the globe earlier in the year, no one, not even the scientific researchers and experts, knew much about it. Today, we...
Agenus Inc (NASDAQ: AGEN) Releases Phase 1b Balstilimab and Botensilimab Study in MMSS CRC
Agenus Inc (NASDAQ: AGEN) has released expanded findings from Phase 1b balstilimab (ant-PD-1) and botensilimab (FC-enhanced anti-CTLA-4) study in microsatellite stable colorectal cancer (MMSS...
MAKE IT MODERN
